カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経皮・経粘膜ドラッグデリバリーシステムの世界市場見通し2023年-2029年

◆英語タイトル：Transdermal & Transmucosal Drug Delivery System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23LY8716）◆商品コード：MMG23LY8716
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年7月
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Transdermal & Transmucosal Drug Delivery System Market 調査レポートは次の情報を含め、グローバルにおけるの経皮・経粘膜ドラッグデリバリーシステム市場規模と予測を収録しています。・世界の経皮・経粘膜ドラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年
・世界の経皮・経粘膜ドラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経皮・経粘膜ドラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経皮ドラッグデリバリーシステム」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経皮・経粘膜ドラッグデリバリーシステムのグローバル主要企業は、3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経皮・経粘膜ドラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経皮・経粘膜ドラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：タイプ別市場シェア、2022年
・経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム

世界の経皮・経粘膜ドラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の経皮・経粘膜ドラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル売上、2018年-2023年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル売上シェア、2022年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル販売量、2018年-2023年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharma

*************************************************************

・調査・分析レポートの概要
経皮・経粘膜ドラッグデリバリーシステム市場の定義
市場セグメント
世界の経皮・経粘膜ドラッグデリバリーシステム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経皮・経粘膜ドラッグデリバリーシステム市場規模
世界の経皮・経粘膜ドラッグデリバリーシステム市場規模：2022年 VS 2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経皮・経粘膜ドラッグデリバリーシステムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経皮・経粘膜ドラッグデリバリーシステム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム
経皮・経粘膜ドラッグデリバリーシステムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
経皮・経粘膜ドラッグデリバリーシステムの用途別グローバル売上・予測

・地域別市場分析
地域別経皮・経粘膜ドラッグデリバリーシステム市場規模 2022年と2029年
地域別経皮・経粘膜ドラッグデリバリーシステム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharma
...

Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products. 
This report aims to provide a comprehensive presentation of the global market for Transdermal & Transmucosal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal & Transmucosal Drug Delivery System. This report contains market size and forecasts of Transdermal & Transmucosal Drug Delivery System in global, including the following market information:
Global Transdermal & Transmucosal Drug Delivery System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transdermal & Transmucosal Drug Delivery System Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Transdermal & Transmucosal Drug Delivery System companies in 2022 (%)
The global Transdermal & Transmucosal Drug Delivery System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Transdermal Drug Delivery System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal & Transmucosal Drug Delivery System include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal & Transmucosal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal & Transmucosal Drug Delivery System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, by Type, 2022 (%)
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Global Transdermal & Transmucosal Drug Delivery System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Transdermal & Transmucosal Drug Delivery System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal & Transmucosal Drug Delivery System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transdermal & Transmucosal Drug Delivery System revenues share in global market, 2022 (%)
Key companies Transdermal & Transmucosal Drug Delivery System sales in global market, 2018-2023 (Estimated), (Units)
Key companies Transdermal & Transmucosal Drug Delivery System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal & Transmucosal Drug Delivery System, market overview.
Chapter 2: Global Transdermal & Transmucosal Drug Delivery System market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal & Transmucosal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal & Transmucosal Drug Delivery System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Transdermal & Transmucosal Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal & Transmucosal Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal & Transmucosal Drug Delivery System Overall Market Size
2.1 Global Transdermal & Transmucosal Drug Delivery System Market Size: 2022 VS 2029
2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transdermal & Transmucosal Drug Delivery System Sales: 2018-2029
3 Company Landscape
3.1 Top Transdermal & Transmucosal Drug Delivery System Players in Global Market
3.2 Top Global Transdermal & Transmucosal Drug Delivery System Companies Ranked by Revenue
3.3 Global Transdermal & Transmucosal Drug Delivery System Revenue by Companies
3.4 Global Transdermal & Transmucosal Drug Delivery System Sales by Companies
3.5 Global Transdermal & Transmucosal Drug Delivery System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal & Transmucosal Drug Delivery System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal & Transmucosal Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal & Transmucosal Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Transdermal & Transmucosal Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal & Transmucosal Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Market Size Markets, 2022 & 2029
4.1.2 Transdermal Drug Delivery System
4.1.3 Transmucosal Drug Delivery System
4.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
4.2.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
4.2.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
4.2.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
4.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
4.3.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
4.3.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
4.3.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
4.4 By Type – Global Transdermal & Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
5.2.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
5.2.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
5.2.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
5.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
5.3.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
5.3.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
5.3.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
5.4 By Application – Global Transdermal & Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Market Size, 2022 & 2029
6.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
6.2.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
6.2.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
6.2.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
6.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
6.3.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
6.3.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
6.3.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.4.2 By Country – North America Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.4.3 US Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.4.4 Canada Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.4.5 Mexico Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.5.2 By Country – Europe Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.5.3 Germany Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.4 France Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.5 U.K. Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.6 Italy Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.7 Russia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.8 Nordic Countries Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.9 Benelux Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.6.2 By Region – Asia Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.6.3 China Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.4 Japan Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.5 South Korea Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.6 Southeast Asia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.7 India Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.7.2 By Country – South America Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.7.3 Brazil Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.7.4 Argentina Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.8.3 Turkey Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.4 Israel Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.5 Saudi Arabia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.6 UAE Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.1.4 3M Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Antares Pharma
7.2.1 Antares Pharma Company Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.2.4 Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.2.5 Antares Pharma Key News & Latest Developments
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Company Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.3.5 Aveva Drug Delivery Systems Key News & Latest Developments
7.4 Corium International
7.4.1 Corium International Company Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.4.4 Corium International Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.4.5 Corium International Key News & Latest Developments
7.5 DURECT
7.5.1 DURECT Company Summary
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.5.4 DURECT Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.5.5 DURECT Key News & Latest Developments
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Company Summary
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.6.4 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.6.5 Pantec Biosolutions Key News & Latest Developments
7.7 Tapemark
7.7.1 Tapemark Company Summary
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.7.4 Tapemark Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.7.5 Tapemark Key News & Latest Developments
7.8 Tesa Labtec
7.8.1 Tesa Labtec Company Summary
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.8.4 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.8.5 Tesa Labtec Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.9.4 Mylan Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Teva
7.10.1 Teva Company Summary
7.10.2 Teva Business Overview
7.10.3 Teva Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.10.4 Teva Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.10.5 Teva Key News & Latest Developments
7.11 Zosano Pharma
7.11.1 Zosano Pharma Company Summary
7.11.2 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Business Overview
7.11.3 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.11.4 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.11.5 Zosano Pharma Key News & Latest Developments
8 Global Transdermal & Transmucosal Drug Delivery System Production Capacity, Analysis
8.1 Global Transdermal & Transmucosal Drug Delivery System Production Capacity, 2018-2029
8.2 Transdermal & Transmucosal Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal & Transmucosal Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal & Transmucosal Drug Delivery System Supply Chain Analysis
10.1 Transdermal & Transmucosal Drug Delivery System Industry Value Chain
10.2 Transdermal & Transmucosal Drug Delivery System Upstream Market
10.3 Transdermal & Transmucosal Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal & Transmucosal Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Transdermal & Transmucosal Drug Delivery System in Global Market
Table 2. Top Transdermal & Transmucosal Drug Delivery System Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Transdermal & Transmucosal Drug Delivery System Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Transdermal & Transmucosal Drug Delivery System Revenue Share by Companies, 2018-2023
Table 5. Global Transdermal & Transmucosal Drug Delivery System Sales by Companies, (Units), 2018-2023
Table 6. Global Transdermal & Transmucosal Drug Delivery System Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Transdermal & Transmucosal Drug Delivery System Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Transdermal & Transmucosal Drug Delivery System Product Type
Table 9. List of Global Tier 1 Transdermal & Transmucosal Drug Delivery System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal & Transmucosal Drug Delivery System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2018-2023
Table 15. By Type - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2024-2029
Table 16. By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2018-2023
Table 20. By Application - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2024-2029
Table 21. By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Transdermal & Transmucosal Drug Delivery System Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2018-2023
Table 25. By Region - Global Transdermal & Transmucosal Drug Delivery System Sales (Units), 2024-2029
Table 26. By Country - North America Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2018-2023
Table 29. By Country - North America Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2024-2029
Table 30. By Country - Europe Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2018-2023
Table 33. By Country - Europe Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2024-2029
Table 34. By Region - Asia Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2018-2023
Table 37. By Region - Asia Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2024-2029
Table 38. By Country - South America Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2018-2023
Table 41. By Country - South America Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Sales, (Units), 2024-2029
Table 46. 3M Company Summary
Table 47. 3M Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 48. 3M Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. 3M Key News & Latest Developments
Table 50. Antares Pharma Company Summary
Table 51. Antares Pharma Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 52. Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Antares Pharma Key News & Latest Developments
Table 54. Aveva Drug Delivery Systems Company Summary
Table 55. Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 56. Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Aveva Drug Delivery Systems Key News & Latest Developments
Table 58. Corium International Company Summary
Table 59. Corium International Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 60. Corium International Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Corium International Key News & Latest Developments
Table 62. DURECT Company Summary
Table 63. DURECT Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 64. DURECT Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. DURECT Key News & Latest Developments
Table 66. Pantec Biosolutions Company Summary
Table 67. Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 68. Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pantec Biosolutions Key News & Latest Developments
Table 70. Tapemark Company Summary
Table 71. Tapemark Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 72. Tapemark Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Tapemark Key News & Latest Developments
Table 74. Tesa Labtec Company Summary
Table 75. Tesa Labtec Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 76. Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Tesa Labtec Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 80. Mylan Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Teva Company Summary
Table 83. Teva Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 84. Teva Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Teva Key News & Latest Developments
Table 86. Zosano Pharma Company Summary
Table 87. Zosano Pharma Transdermal & Transmucosal Drug Delivery System Product Offerings
Table 88. Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Zosano Pharma Key News & Latest Developments
Table 90. Transdermal & Transmucosal Drug Delivery System Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 91. Global Transdermal & Transmucosal Drug Delivery System Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Transdermal & Transmucosal Drug Delivery System Production by Region, 2018-2023 (Units)
Table 93. Global Transdermal & Transmucosal Drug Delivery System Production by Region, 2024-2029 (Units)
Table 94. Transdermal & Transmucosal Drug Delivery System Market Opportunities & Trends in Global Market
Table 95. Transdermal & Transmucosal Drug Delivery System Market Drivers in Global Market
Table 96. Transdermal & Transmucosal Drug Delivery System Market Restraints in Global Market
Table 97. Transdermal & Transmucosal Drug Delivery System Raw Materials
Table 98. Transdermal & Transmucosal Drug Delivery System Raw Materials Suppliers in Global Market
Table 99. Typical Transdermal & Transmucosal Drug Delivery System Downstream
Table 100. Transdermal & Transmucosal Drug Delivery System Downstream Clients in Global Market
Table 101. Transdermal & Transmucosal Drug Delivery System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Transdermal & Transmucosal Drug Delivery System Segment by Type in 2022
Figure 2. Transdermal & Transmucosal Drug Delivery System Segment by Application in 2022
Figure 3. Global Transdermal & Transmucosal Drug Delivery System Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal & Transmucosal Drug Delivery System Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029 (US$, Mn)
Figure 7. Transdermal & Transmucosal Drug Delivery System Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Transdermal & Transmucosal Drug Delivery System Revenue in 2022
Figure 9. By Type - Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 11. By Type - Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 12. By Type - Global Transdermal & Transmucosal Drug Delivery System Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 15. By Application - Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 16. By Application - Global Transdermal & Transmucosal Drug Delivery System Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 20. By Region - Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 21. By Country - North America Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 22. By Country - North America Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 23. US Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 28. Germany Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 29. France Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 37. China Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 41. India Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 43. By Country - South America Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 44. Brazil Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
Figure 48. Turkey Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Transdermal & Transmucosal Drug Delivery System Revenue, (US$, Mn), 2018-2029
Figure 52. Global Transdermal & Transmucosal Drug Delivery System Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Transdermal & Transmucosal Drug Delivery System by Region, 2022 VS 2029
Figure 54. Transdermal & Transmucosal Drug Delivery System Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 経皮・経粘膜ドラッグデリバリーシステムの世界市場見通し2023年-2029年(Transdermal & Transmucosal Drug Delivery System Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ドラッグデリバリー（薬物送達）の世界市場予測（～2030）
  • 薄膜ドラッグデリバリーの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆